E2F activity determines mitosis versus whole-genome duplication in G2-arrested cells
While mitogenic signaling is known to regulate cell-cycle entry during the G1 phase, its function in the G2 phase remains elusive. Here we show that mitogenic signaling controls whether G2-arrested cells proceed through mitosis or undergo whole-genome duplication. Although mitogenic signaling is not required for the G2/M transition under normal conditions, it modulates E2F transcriptional activity via c-Myc. When G2 arrest occurs due to CDK4/6 and CDK2 suppression, E2F activity levels determine the status of APC/C inactivation and the CDK2-Rb feedback loop. Upon release from G2 arrest, cells maintaining APC/C inactivation promptly induce CDK2 activation and FoxM1 phosphorylation, driving mitotic entry. Conversely, APC/C reactivation degrades cyclin A and abolishes the CDK2-Rb loop, necessitating CDK4/6 activation for cell-cycle re-entry. This regulatory mechanism mirrors the G1-phase process, resulting in whole-genome duplication. In cancer cells, this process promotes genome instability and oncogene amplification, contributing to aggressive behavior. These findings reveal a previously unrecognized mitogen-dependent checkpoint that governs cell fate in the G2 phase.
Authors
- Hee Won Yang (ORCID: https://orcid.org/0000-0002-0000-8091)
- Sungsoo Kim (ORCID: https://orcid.org/0000-0003-0949-4214)
- Jae Hyun Kim (ORCID: https://orcid.org/0000-0003-2824-0113)
- Jessica Armand
Institutions
- Columbia University Irving Medical Center (US)
- Columbia University (US)
Publication Details
- Journal
- Nature Communications
- Published
- 2025-07-21
- DOI
- https://doi.org/10.1038/s41467-025-62061-w
- Citations
- 6
- Primary Topic
- Cancer-related Molecular Pathways
- Type
- article
- Field-Weighted Citation Impact
- 5.23
Funders
- American Cancer Society
- V Foundation for Cancer Research
- Melanoma Research Foundation
- Melanoma Research Alliance
- National Institutes of Health
- National Institute of General Medical Sciences